ArticleBMC research notes2026
Hematological and leukocyte morphometric indices as low-cost diagnostic adjuncts in acute coronary syndromes.
Article in BMC research notes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveAcute Coronary Syndromes (ACS) remain a major cause of morbidity and mortality, particularly in resource-limited settings where access to advanced diagnostics may be constrained. This study aimed to evaluate the utility of routine hematological indices and leukocyte morphometric parameters-volume, conductivity, and scatter (VCS)-as low-cost adjuncts for identifying ACS and differentiating its subtypes. RESULTS DESCRIPTION: This cross-sectional study included 291 adults (151 ACS patients and 140 healthy controls) evaluated between January 2022 and August 2023. Compared with controls, ACS patients had significantly higher total leukocyte counts, lower hemoglobin levels, increased mean platelet volume (MPV), reduced neutrophil conductivity (MN-C-NE), and increased monocyte scatter parameters (MN-LALS-MO, MN-AL2-MO) (all p < 0.01). On L1-regularized multivariable logistic regression, elevated WBC count, reduced hemoglobin, increased MPV, decreased neutrophil conductivity, and increased monocyte scatter indices independently predicted ACS. The combined model demonstrated excellent discriminatory performance (AUC 0.98 ± 0.02). However, discrimination between ACS subtypes was limited, with poor performance for differentiating STEMI from unstable angina and NSTEMI (AUC 0.63-0.65, p > 0.05). These findings suggest that hematological and VCS parameters are effective for identifying ACS but have limited utility in subtype differentiation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.